As of 2025-07-12, the Relative Valuation of Intercept Pharmaceuticals Inc (ICPT) is (26.49) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.00 USD, the upside of Intercept Pharmaceuticals Inc based on Relative Valuation is -239.4%.
The range of the Relative Valuation is (21.99) - (30.44) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.6x - 25.0x | 19.0x |
| Forward P/E multiples | 14.9x - 20.7x | 16.9x |
| Fair Price | (21.99) - (30.44) | (26.49) |
| Upside | -215.7% - -260.2% | -239.4% |
| Date | P/E |